Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Franklin W. Stahl, renowned for his groundbreaking work on DNA replication, has died at 95. His 1957-58 experiment with Matthew Meselson reshaped the understanding of genetics and paved the way for future discoveries.
Nestor Montalvo, a retired NY cop, faced a life-threatening ischemic stroke that left him fighting for survival. After a critical hospital intervention, he shares his incredible journey of recovery and the lessons learned about life.
Explore the often-overlooked benefits of radiation therapy as a viable option for cancer treatment. This personal account reveals the supportive environment and the human connections that can make a challenging experience more bearable.
Princess Kate shares her emotional journey through cancer recovery, describing it as a 'roller coaster.' During a visit to Colchester Hospital, she emphasizes the importance of community support and finding a new normal after treatment.
A groundbreaking study has identified knee braces as the most effective treatment for osteoarthritis pain. While many therapies were tested, the simplicity of the knee brace shines through. But can patients be convinced to wear them?
Richard Schlueter, battling metastatic cancer, faces a desperate wait for experimental treatment as NIH staff cuts delay his therapy. His story sheds light on the critical impact of workforce reductions on patient care.
A new study indicates that a single dose of psilocybin can alleviate depression for up to five years, offering hope for those with major depressive disorder. This groundbreaking research highlights the potential of psychedelics in mental health treatment.
